New chemo approach targets liver first in pancreatic cancer fight
NCT ID NCT05634720
First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 34 times
Summary
This study tests whether giving a single dose of chemotherapy directly into the liver artery, before standard treatment, is safe and feasible for people with localized pancreatic cancer. It includes 20 adults whose cancer can be surgically removed. The goal is to see if this added step can help control the disease without causing extra harm.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Duke University Health System
Durham, North Carolina, 27710, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.